Diastereoselective Synthesis of a -1,3-Disubstituted Cyclobutane Carboxylic Acid Scaffold for TAK-828F, a Potent Retinoic Acid Receptor-Related Orphan Receptor (ROR)-γt Inverse Agonist.

J Org Chem

Process Chemistry, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 17-85 Jusohonmachi 2-Chome, Yodogawa-ku, Osaka 532-8686, Japan.

Published: September 2021

A scalable synthesis of the -1,3-disubstituted cyclobutane carboxylic acid scaffold of TAK-828F () has been developed, featuring the diastereoselective reduction of a cyclobutylidene Meldrum's acid derivative with NaBH. Controlling acidic impurities was crucial for improving the diastereomeric ratio by recrystallization. Furthermore, reaction optimization and the streamlining of several steps established a scalable synthetic method free from column chromatography purification with an overall yield improved from 23 to 39%.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.1c00970DOI Listing

Publication Analysis

Top Keywords

synthesis -13-disubstituted
8
-13-disubstituted cyclobutane
8
cyclobutane carboxylic
8
carboxylic acid
8
acid scaffold
8
scaffold tak-828f
8
diastereoselective synthesis
4
acid
4
tak-828f potent
4
potent retinoic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!